Privium Fund Management (Uk) LTD Kronos Bio, Inc. Transaction History

Privium Fund Management (Uk) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$1.34 - $2.62 $103,474 - $202,316	-77,220 Reduced 20.9%	292,182 $426,000
Q4 2022 Feb 09, 2023	SELL	$1.44 - $3.44 $397,337 - $949,195	-275,929 Reduced 42.76%	369,402 $598,000
Q3 2022 Nov 01, 2022	BUY	$3.35 - $5.55 $720,189 - $1.19 Million	214,982 Added 49.96%	645,331 $2.16 Million
Q2 2022 Jul 28, 2022	BUY	$3.12 - $7.52 $1.34 Million - $3.24 Million	430,349 New	430,349 $1.57 Million

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $48.8M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Privium Fund Management (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Privium Fund Management (Uk) LTD with notifications on news.